+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
WHIM Syndrome Market - Global Forecast 2025-2030- Product Image
WHIM Syndrome Market - Global Forecast 2025-2030- Product Image
Sale

WHIM Syndrome Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055741
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The WHIM Syndrome market presents a rapidly evolving landscape where advancements in genetic diagnostics, targeted therapies, and regulatory frameworks are enabling more effective and patient-centric solutions for a rare immunodeficiency disorder. Senior decision-makers can leverage a dynamic blend of clinical innovation, regulatory incentives, and collaborative care models to drive sustainable strategic growth.

Market Snapshot: WHIM Syndrome Market Growth and Opportunity

The WHIM Syndrome market grew from USD 459.77 million in 2024 to USD 485.75 million in 2025. It is expected to continue expanding at a compound annual growth rate (CAGR) of 5.87%, reaching USD 647.77 million by 2030. This consistent upward trajectory is fueled by breakthroughs in precision medicine, growing access to advanced diagnostics, and new therapeutic interventions that address both clinical needs and unmet market demand.

Scope & Segmentation of WHIM Syndrome Market

This research provides a structured analysis of WHIM Syndrome, unraveling market dynamics across the full spectrum of genetic, clinical, and therapeutic advances. Key segmentations and regions are as follows:

  • Treatment Options: Granulocyte-Colony Stimulating Factor, Immunoglobulin Replacement Therapy, Prophylactic Antibiotic Treatment
  • Mode of Administration: Injectable, Oral
  • Therapeutic Applications: Autoimmune Conditions (Endocrine Disorders, Rheumatological Syndromes), Hematological Disorders (Leukopenia, Thrombocytopenia), Infection Management
  • End User Settings: Home Care Settings, Hospitals, Specialty Clinics
  • Regional Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, and more), Asia-Pacific (including China, India, Japan, Australia, South Korea and others)
  • Leading Companies: Aetna Inc., AstraZeneca Plc, Beijing Wantai Biolog Pha Ent Co Ltd, Bristol-Myers Squibb Co., Dr. Reddy’s Laboratories Ltd, Eugia Pharma Inc., GlaxoSmithKline Plc (GSK), Horizonscan geneesmiddelen, Incyte Corporation, Innovate Biopharmaceuticals, Inc., Intercept Pharmaceuticals, Johnson & Johnson, Merck & Co., Inc, Pfizer Inc., Roche Holding AG, Sanofi S.A., Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Company Limited, Walvax Biotechnology Co., Ltd., X4 Pharmaceuticals, Inc.
  • Diagnostic Innovations: Widespread adoption of next-generation sequencing and flow cytometry assays, supported by digital health solutions for real-time patient monitoring

Key Takeaways for Senior Decision-Makers

  • Progress in CXCR4-targeted therapies and gene-editing platforms indicates a shift toward curative interventions, moving beyond supportive care models.
  • Digital healthcare integration, such as telemedicine and remote monitoring, underpins more effective and timely patient management, particularly in home settings.
  • Regulatory incentives—including breakthrough designations and orphan drug pathways—are accelerating clinical development and market entry for innovative treatments.
  • Strategic partnerships among biopharmaceutical firms, academic centers, and patient advocacy groups are streamlining research, enhancing trial recruitment, and supporting data-driven decision-making.
  • Market segmentation highlights diverse adoption patterns, necessitating tailored strategies according to care setting, modality, and geographic region.

Tariff Impact: Navigating Supply Chain and Cost Pressures

Upcoming U.S. tariff measures on specialty reagents and active pharmaceutical ingredients are increasing procurement costs and prompting manufacturers to re-evaluate supply chains. Companies are shifting toward domestic production and vertical integration to stabilize resources and manage cost volatility. Payers are responding by demanding innovative risk-sharing contracts, while clinical operations are refocusing on regions with strong biotech infrastructure to minimize logistical challenges. These adaptations are shaping a more resilient supply network.

Methodology & Data Sources

This report utilizes a comprehensive mixed methodology, combining exhaustive secondary research with expert interviews. Specialist insights from hematologists, immunologists, and regulatory professionals are triangulated against quantitative market segmentation and scenario modeling. Data integrity is maintained through internal peer review and real-world evidence validation.

Why This Report Matters

  • Enables informed investment and operational strategies by synthesizing robust clinical, regulatory, and commercial intelligence on the WHIM Syndrome market.
  • Supports market access planning with clear segmentation, technology trends, and analysis of supply chain pressures—ensuring alignment with emerging therapeutic and reimbursement frameworks.

Conclusion

The WHIM Syndrome market is entering a new era shaped by targeted innovation, resilient supply models, and coordinated stakeholder partnerships. This report delivers actionable insights for leaders aiming to advance care, strengthen growth opportunities, and address the full range of market challenges.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in CXCR4 antagonist therapies demonstrating improved leukocyte mobilization in WHIM syndrome
5.2. Emerging gene editing approaches targeting CXCR4 mutations for long term remission in WHIM syndrome
5.3. Challenges in rare disease clinical trial recruitment and regulatory pathways for WHIM syndrome therapies
5.4. Increasing patient advocacy and real world evidence initiatives driving awareness and funding for WHIM syndrome
5.5. Integration of digital health solutions for monitoring neutrophil counts in WHIM syndrome patients
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. WHIM Syndrome Market, by Treatment
8.1. Introduction
8.2. Granulocyte-Colony Stimulating Factor
8.3. Immunoglobulin Replacement Therapy
8.4. Prophylactic Antibiotic Treatment
9. WHIM Syndrome Market, by Mode of Administration
9.1. Introduction
9.2. Injectable
9.3. Oral
10. WHIM Syndrome Market, by Therapeutic Application
10.1. Introduction
10.2. Autoimmune Conditions
10.2.1. Endocrine Disorders
10.2.2. Rheumatological Syndromes
10.3. Hematological Disorders
10.3.1. Leukopenia
10.3.2. Thrombocytopenia
10.4. Infection Management
11. WHIM Syndrome Market, by End User
11.1. Introduction
11.2. Home Care Settings
11.3. Hospitals
11.4. Specialty Clinics
12. Americas WHIM Syndrome Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa WHIM Syndrome Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific WHIM Syndrome Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Aetna Inc.
15.3.2. AstraZeneca Plc
15.3.3. Beijing Wantai Biolog Pha Ent Co Ltd
15.3.4. Bristol-Myers Squibb Co.
15.3.5. Dr. Reddy’s Laboratories Ltd
15.3.6. Eugia Pharma Inc.
15.3.7. GlaxoSmithKline Plc (GSK)
15.3.8. Horizonscan geneesmiddelen
15.3.9. Incyte Corporation
15.3.10. Innovate Biopharmaceuticals, Inc.
15.3.11. Intercept Pharmaceuticals
15.3.12. Johnson & Johnson
15.3.13. Merck & Co., Inc
15.3.14. Pfizer Inc.
15.3.15. Roche Holding AG
15.3.16. Sanofi S.A.
15.3.17. Serum Institute of India Pvt. Ltd.
15.3.18. Takeda Pharmaceutical Company Limited
15.3.19. Walvax Biotechnology Co., Ltd.
15.3.20. X4 Pharmaceuticals, Inc.
16. Research AI17. Research Statistics18. Research Contacts19. Research Articles20. Appendix
List of Figures
FIGURE 1. WHIM SYNDROME MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL WHIM SYNDROME MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL WHIM SYNDROME MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL WHIM SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL WHIM SYNDROME MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL WHIM SYNDROME MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS WHIM SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS WHIM SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES WHIM SYNDROME MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES WHIM SYNDROME MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA WHIM SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA WHIM SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC WHIM SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC WHIM SYNDROME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. WHIM SYNDROME MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. WHIM SYNDROME MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. WHIM SYNDROME MARKET: RESEARCHAI
FIGURE 24. WHIM SYNDROME MARKET: RESEARCHSTATISTICS
FIGURE 25. WHIM SYNDROME MARKET: RESEARCHCONTACTS
FIGURE 26. WHIM SYNDROME MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. WHIM SYNDROME MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL WHIM SYNDROME MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL WHIM SYNDROME MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL WHIM SYNDROME MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL WHIM SYNDROME MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL WHIM SYNDROME MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL WHIM SYNDROME MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL WHIM SYNDROME MARKET SIZE, BY GRANULOCYTE-COLONY STIMULATING FACTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL WHIM SYNDROME MARKET SIZE, BY GRANULOCYTE-COLONY STIMULATING FACTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL WHIM SYNDROME MARKET SIZE, BY IMMUNOGLOBULIN REPLACEMENT THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL WHIM SYNDROME MARKET SIZE, BY IMMUNOGLOBULIN REPLACEMENT THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL WHIM SYNDROME MARKET SIZE, BY PROPHYLACTIC ANTIBIOTIC TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL WHIM SYNDROME MARKET SIZE, BY PROPHYLACTIC ANTIBIOTIC TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL WHIM SYNDROME MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL WHIM SYNDROME MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL WHIM SYNDROME MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL WHIM SYNDROME MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL WHIM SYNDROME MARKET SIZE, BY ENDOCRINE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL WHIM SYNDROME MARKET SIZE, BY ENDOCRINE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL WHIM SYNDROME MARKET SIZE, BY RHEUMATOLOGICAL SYNDROMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL WHIM SYNDROME MARKET SIZE, BY RHEUMATOLOGICAL SYNDROMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL WHIM SYNDROME MARKET SIZE, BY LEUKOPENIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL WHIM SYNDROME MARKET SIZE, BY LEUKOPENIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL WHIM SYNDROME MARKET SIZE, BY THROMBOCYTOPENIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL WHIM SYNDROME MARKET SIZE, BY THROMBOCYTOPENIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL WHIM SYNDROME MARKET SIZE, BY INFECTION MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL WHIM SYNDROME MARKET SIZE, BY INFECTION MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL WHIM SYNDROME MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL WHIM SYNDROME MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL WHIM SYNDROME MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL WHIM SYNDROME MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL WHIM SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL WHIM SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS WHIM SYNDROME MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS WHIM SYNDROME MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES WHIM SYNDROME MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES WHIM SYNDROME MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 79. CANADA WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 80. CANADA WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 81. CANADA WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 82. CANADA WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 83. CANADA WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 84. CANADA WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 85. CANADA WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 86. CANADA WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 87. CANADA WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 88. CANADA WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 89. CANADA WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. CANADA WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. MEXICO WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 92. MEXICO WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 93. MEXICO WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 94. MEXICO WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 95. MEXICO WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 96. MEXICO WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 97. MEXICO WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 98. MEXICO WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 99. MEXICO WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 100. MEXICO WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 101. MEXICO WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. MEXICO WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. ARGENTINA WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 116. ARGENTINA WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA WHIM SYNDROME MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA WHIM SYNDROME MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 142. UNITED KINGDOM WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. GERMANY WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 154. GERMANY WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 155. GERMANY WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 156. GERMANY WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 157. GERMANY WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. GERMANY WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. GERMANY WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 160. GERMANY WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 161. GERMANY WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 162. GERMANY WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 163. GERMANY WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. GERMANY WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. FRANCE WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 166. FRANCE WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 167. FRANCE WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 168. FRANCE WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 169. FRANCE WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. FRANCE WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. FRANCE WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 172. FRANCE WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 173. FRANCE WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 174. FRANCE WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 175. FRANCE WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. FRANCE WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. RUSSIA WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 178. RUSSIA WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 179. RUSSIA WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 180. RUSSIA WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. ITALY WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 190. ITALY WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 191. ITALY WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 192. ITALY WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 193. ITALY WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. ITALY WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. ITALY WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 196. ITALY WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 197. ITALY WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 198. ITALY WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 199. ITALY WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. ITALY WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. SPAIN WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 202. SPAIN WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 203. SPAIN WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 204. SPAIN WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 205. SPAIN WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. SPAIN WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. SPAIN WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 208. SPAIN WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 209. SPAIN WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 210. SPAIN WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 211. SPAIN WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. SPAIN WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 226. SAUDI ARABIA WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 228. SAUDI ARABIA WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 238. SOUTH AFRICA WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 240. SOUTH AFRICA WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. DENMARK WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 250. DENMARK WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 251. DENMARK WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 252. DENMARK WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 253. DENMARK WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. DENMARK WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. DENMARK WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 256. DENMARK WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 257. DENMARK WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 258. DENMARK WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 259. DENMARK WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. DENMARK WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. NETHERLANDS WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 262. NETHERLANDS WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 263. NETHERLANDS WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 264. NETHERLANDS WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. QATAR WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 274. QATAR WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 275. QATAR WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. QATAR WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. QATAR WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. QATAR WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. QATAR WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 280. QATAR WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 281. QATAR WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 282. QATAR WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 283. QATAR WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. QATAR WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. FINLAND WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 286. FINLAND WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 287. FINLAND WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 288. FINLAND WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 289. FINLAND WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. FINLAND WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. FINLAND WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 292. FINLAND WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 293. FINLAND WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 294. FINLAND WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 295. FINLAND WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. FINLAND WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. SWEDEN WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 298. SWEDEN WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 299. SWEDEN WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 300. SWEDEN WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. NIGERIA WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 310. NIGERIA WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 311. NIGERIA WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 312. NIGERIA WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 313. NIGERIA WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 314. NIGERIA WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 315. NIGERIA WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 316. NIGERIA WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 317. NIGERIA WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 318. NIGERIA WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. EGYPT WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 322. EGYPT WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 323. EGYPT WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 324. EGYPT WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 325. EGYPT WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 326. EGYPT WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 327. EGYPT WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 328. EGYPT WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 329. EGYPT WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 330. EGYPT WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 331. EGYPT WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 332. EGYPT WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 333. TURKEY WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 334. TURKEY WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 335. TURKEY WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 336. TURKEY WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 337. TURKEY WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 338. TURKEY WHIM SYNDROME MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 339. TURKEY WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2018-2024 (USD MILLION)
TABLE 340. TURKEY WHIM SYNDROME MARKET SIZE, BY AUTOIMMUNE CONDITIONS, 2025-2030 (USD MILLION)
TABLE 341. TURKEY WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 342. TURKEY WHIM SYNDROME MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 343. TURKEY WHIM SYNDROME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 344. TURKEY WHIM SYNDROME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 345. ISRAEL WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 346. ISRAEL WHIM SYNDROME MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 347. ISRAEL WHIM SYNDROME MARKET SIZE, BY MODE OF ADMINISTRATION,

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this WHIM Syndrome market report include:
  • Aetna Inc.
  • AstraZeneca Plc
  • Beijing Wantai Biolog Pha Ent Co Ltd
  • Bristol-Myers Squibb Co.
  • Dr. Reddy’s Laboratories Ltd
  • Eugia Pharma Inc.
  • GlaxoSmithKline Plc (GSK)
  • Horizonscan geneesmiddelen
  • Incyte Corporation
  • Innovate Biopharmaceuticals, Inc.
  • Intercept Pharmaceuticals
  • Johnson & Johnson
  • Merck & Co., Inc
  • Pfizer Inc.
  • Roche Holding AG
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • Takeda Pharmaceutical Company Limited
  • Walvax Biotechnology Co., Ltd.
  • X4 Pharmaceuticals, Inc.

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 485.75 million
Forecasted Market Value ( USD ) by 2030 $ 647.77 million
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

WHIM Syndrome - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Image

WHIM Syndrome - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Whim Syndrome Market - Product Image

Whim Syndrome Market

  • Report
  • 250 Pages
  • Global
From
WHIM Syndrome - Pipeline Insight, 2025 - Product Image

WHIM Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • 40 Pages
  • Global
From
Hunter Syndrome Treatment Market - Global Forecast 2025-2030 - Product Image

Hunter Syndrome Treatment Market - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Hunter Syndrome Treatment Market Size, Share & Trends Analysis Report by Type (Enzyme Replacement Therapy, Hematopoietic Stem Cell Transplant), Route Of Administration, End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Hunter Syndrome Treatment Market Size, Share & Trends Analysis Report by Type (Enzyme Replacement Therapy, Hematopoietic Stem Cell Transplant), Route Of Administration, End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From

About the Whim Syndrome Drug Market

The Whim Syndrome Drug market is a subset of the Immune Disorders Drugs market. It is composed of drugs used to treat Whim Syndrome, a rare, genetic disorder characterized by recurrent infections, skin lesions, and autoimmunity. These drugs are used to reduce the severity of symptoms and improve the quality of life for those affected by the disorder. The Whim Syndrome Drug market is composed of both generic and branded drugs. Generic drugs are typically cheaper than branded drugs, but may not be as effective. Branded drugs are typically more expensive, but may be more effective in treating the disorder. Some companies in the Whim Syndrome Drug market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.